Skip to main content

Table 1 Baseline characteristics of patients analyzed

From: Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial

 

Haloperidol (n = 33)

Quetiapine (n = 40)

p value

Age (years ± SD)

30.76 ± 3.93

31.29 ± 3.42

0.5396

Sex (M/F)

21/12

25/15

0.92

Duration of illness (months ± SD)

4.82 ± 1.62

5.03 ± 2.14

0.6438

Marital status (unmarried/married)

19/14

23/17

0.994

Employment status (unemployed/employed)

22/11

28/12

0.76

Education (above/below secondary education)

23/10

31/9

0.449

Income (satisfactory/unsatisfactory)

7/26

8/32

0.898

Type of schizophrenia (paranoid/non-paranoid)

24/9

32/8

0.464

  1. SD = standard deviation.